IL123431A - Mercaptoalkyl peptidil compounds with imidazole transducer and their use as metallic protonase matrix (MMP) compounds and / or tumor cause factor (TNF) - Google Patents
Mercaptoalkyl peptidil compounds with imidazole transducer and their use as metallic protonase matrix (MMP) compounds and / or tumor cause factor (TNF)Info
- Publication number
- IL123431A IL123431A IL12343196A IL12343196A IL123431A IL 123431 A IL123431 A IL 123431A IL 12343196 A IL12343196 A IL 12343196A IL 12343196 A IL12343196 A IL 12343196A IL 123431 A IL123431 A IL 123431A
- Authority
- IL
- Israel
- Prior art keywords
- alkyl
- methyl
- amino
- pentanoyl
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9523828.3A GB9523828D0 (en) | 1995-11-22 | 1995-11-22 | Compounds |
GBGB9607121.2A GB9607121D0 (en) | 1996-04-04 | 1996-04-04 | Compounds |
PCT/GB1996/002892 WO1997019075A1 (en) | 1995-11-22 | 1996-11-22 | Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
Publications (2)
Publication Number | Publication Date |
---|---|
IL123431A0 IL123431A0 (en) | 1998-09-24 |
IL123431A true IL123431A (en) | 2001-05-20 |
Family
ID=26308152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12343196A IL123431A (en) | 1995-11-22 | 1996-11-22 | Mercaptoalkyl peptidil compounds with imidazole transducer and their use as metallic protonase matrix (MMP) compounds and / or tumor cause factor (TNF) |
Country Status (19)
Country | Link |
---|---|
US (1) | US6048841A (no) |
EP (1) | EP0874842B1 (no) |
JP (1) | JP2000500482A (no) |
KR (1) | KR19990067687A (no) |
CN (1) | CN1072667C (no) |
AT (1) | ATE215946T1 (no) |
AU (1) | AU711907B2 (no) |
BR (1) | BR9611636A (no) |
CA (1) | CA2229438C (no) |
CZ (1) | CZ291337B6 (no) |
DE (1) | DE69620639T2 (no) |
ES (1) | ES2172690T3 (no) |
HU (1) | HUP9904131A3 (no) |
IL (1) | IL123431A (no) |
MX (1) | MX9804052A (no) |
NO (1) | NO982290D0 (no) |
NZ (1) | NZ322565A (no) |
PL (1) | PL326710A1 (no) |
WO (1) | WO1997019075A1 (no) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6673927B2 (en) | 1996-02-16 | 2004-01-06 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Farnesyl transferase inhibitors |
US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
RU2201931C2 (ru) | 1996-11-20 | 2003-04-10 | Биомежер Инкорпорэйтед | Ингибиторы фарнезилтрансферазы и способы ингибирования фарнезилтрансферазы |
CA2876779A1 (en) | 2000-05-12 | 2001-11-22 | Genzyme Corporation | Modulators of tnf-.alpha. signaling |
ES2208595T3 (es) | 2000-05-15 | 2004-06-16 | Darwin Discovery Limited | Derivados del acido hidroxamico. |
SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0103710D0 (sv) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
CN100503608C (zh) * | 2002-01-07 | 2009-06-24 | 卫材R&D管理株式会社 | 脱氮嘌呤及其用途 |
SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
ES2363914T3 (es) * | 2002-11-21 | 2011-08-19 | Genzyme Corporation | Utilización de un derivado de diamida para inhibir el rechazo crónico de un transplante. |
US7217718B2 (en) * | 2002-11-21 | 2007-05-15 | Genzyme Corporation | Induction of immune tolerance |
US20040259744A1 (en) * | 2003-12-19 | 2004-12-23 | Meidong Yang | Skin and hair cleansers containing sulfur |
US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
SE0403086D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
SE0403085D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
PL227790B1 (pl) | 2015-08-13 | 2018-01-31 | Slaski Univ Medyczny W Katowicach | Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE150452T1 (de) * | 1992-04-07 | 1997-04-15 | British Biotech Pharm | Hydroxamsäure enthaltende collagenase-inhibitoren und cytokinaktivitätsinhibitoren |
GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
GB9404046D0 (en) * | 1994-03-03 | 1994-04-20 | Smithkline Beecham Corp | Novel compounds |
CN1193978A (zh) * | 1994-10-05 | 1998-09-23 | 奇罗斯恩有限公司 | 肽基化合物和它们作为金属蛋白酶抑制剂的医疗用途 |
-
1996
- 1996-11-22 KR KR1019980703717A patent/KR19990067687A/ko not_active Application Discontinuation
- 1996-11-22 PL PL96326710A patent/PL326710A1/xx unknown
- 1996-11-22 AU AU76343/96A patent/AU711907B2/en not_active Ceased
- 1996-11-22 ES ES96939208T patent/ES2172690T3/es not_active Expired - Lifetime
- 1996-11-22 CA CA002229438A patent/CA2229438C/en not_active Expired - Fee Related
- 1996-11-22 CN CN96198507A patent/CN1072667C/zh not_active Expired - Fee Related
- 1996-11-22 HU HU9904131A patent/HUP9904131A3/hu unknown
- 1996-11-22 EP EP96939208A patent/EP0874842B1/en not_active Expired - Lifetime
- 1996-11-22 DE DE69620639T patent/DE69620639T2/de not_active Expired - Fee Related
- 1996-11-22 IL IL12343196A patent/IL123431A/en not_active IP Right Cessation
- 1996-11-22 US US08/755,071 patent/US6048841A/en not_active Expired - Fee Related
- 1996-11-22 BR BR9611636-6A patent/BR9611636A/pt unknown
- 1996-11-22 WO PCT/GB1996/002892 patent/WO1997019075A1/en not_active Application Discontinuation
- 1996-11-22 AT AT96939208T patent/ATE215946T1/de not_active IP Right Cessation
- 1996-11-22 CZ CZ19981455A patent/CZ291337B6/cs not_active IP Right Cessation
- 1996-11-22 JP JP9519522A patent/JP2000500482A/ja not_active Ceased
- 1996-11-22 NZ NZ322565A patent/NZ322565A/xx unknown
-
1998
- 1998-05-20 NO NO982290A patent/NO982290D0/no not_active Application Discontinuation
- 1998-05-21 MX MX9804052A patent/MX9804052A/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL123431A0 (en) | 1998-09-24 |
NO982290L (no) | 1998-05-20 |
HUP9904131A3 (en) | 2002-04-29 |
NO982290D0 (no) | 1998-05-20 |
NZ322565A (en) | 1999-11-29 |
WO1997019075A1 (en) | 1997-05-29 |
AU711907B2 (en) | 1999-10-21 |
DE69620639T2 (de) | 2002-10-17 |
JP2000500482A (ja) | 2000-01-18 |
CN1202895A (zh) | 1998-12-23 |
MX9804052A (es) | 1998-09-30 |
ES2172690T3 (es) | 2002-10-01 |
CZ291337B6 (cs) | 2003-02-12 |
KR19990067687A (ko) | 1999-08-25 |
CN1072667C (zh) | 2001-10-10 |
CA2229438A1 (en) | 1997-05-29 |
DE69620639D1 (de) | 2002-05-16 |
EP0874842B1 (en) | 2002-04-10 |
PL326710A1 (en) | 1998-10-26 |
CZ145598A3 (cs) | 1998-08-12 |
US6048841A (en) | 2000-04-11 |
HUP9904131A2 (hu) | 2000-06-28 |
AU7634396A (en) | 1997-06-11 |
CA2229438C (en) | 2006-01-17 |
ATE215946T1 (de) | 2002-04-15 |
BR9611636A (pt) | 1999-12-28 |
EP0874842A1 (en) | 1998-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0874842B1 (en) | Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) | |
US5872146A (en) | Mercapto alkyl peptidyl compounds having MMP and TNF inhibitory activity | |
EP0859784B1 (en) | Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation | |
CZ99697A3 (en) | Peptidyl compounds and their therapeutic use as metaloproteinase inhibitors | |
EP0728144A1 (en) | Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases | |
AU701279B2 (en) | Peptide compounds which inhibit metalloproteinase and TNF liberation and their therapeutic uses | |
AU706064B2 (en) | Peptide compounds which inhibit metalloproteinase and TNF liberation, and their therapeutic use | |
AU710502B2 (en) | Peptidyl compounds which inhibit metalloproteinase and TNF liberation and their therapeutic use | |
EP0891329B1 (en) | Peptidyl compounds having mmp and tnf inhibitory activity | |
EP0891328B1 (en) | Peptidyl compounds having mmp and tnf inhibitory activity | |
AU692102B2 (en) | Peptidyl compounds and their therapeutic use | |
WO1997012861A1 (en) | Mercaptoamide derivatives and their therapeutic use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
RH1 | Patent not in force |